Filter
504
Filtered Results: 504
Text search:
in
vitro
diagnostic
tests
Featured
Recommendations
68
New Publications
105
Language
Document type
No document type
232
Guidelines
130
Studies & Reports
60
Manuals
45
Strategic & Response Plan
14
Fact sheets
14
Training Material
5
Situation Updates
2
Resource Platforms
2
Countries / Regions
India
26
Germany
15
Global
12
Latin America and the Carribbean
12
South Africa
11
Africa
10
Western and Central Europe
10
Kenya
7
Russia
7
Tanzania
6
Rwanda
5
Brazil
5
Ethiopia
5
Cameroon
4
Nigeria
4
Eastern Europe
4
Namibia
4
Nepal
3
Senegal
3
Congo-Brazzaville
3
Burkina Faso
3
Malawi
3
West and Central Africa
3
Uganda
3
Zambia
3
Ukraine
2
Benin
2
Sierra Leone
2
Togo
2
Niger
2
Haiti
2
Asia
2
Venezuela
2
Congo, Democratic Republic of
2
Middle East and North Africa
2
France
2
East and Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Bangladesh
2
Mali
2
Myanmar / Burma
2
Madagascar
2
Eswatini/ Swaziland
2
Colombia
1
Turkey
1
Gambia
1
Chile
1
Syria
1
Albania
1
Canada
1
Laos
1
Burundi
1
Peru
1
Zimbabwe
1
Philippines
1
Guinea
1
USA
1
South–East Asia Region
1
Luxembourg
1
North America
1
Belgium
1
Southern Africa
1
Bolivia
1
Djibouti
1
Yemen
1
Angola
1
South Sudan
1
Indonesia
1
Liberia
1
Authors & Publishers
Publication Years
Category
Guidelines
50
Policies & Guidelines HIV & TB
29
COVID-19
28
TB
22
Drugs & Medical Equipment
19
Hepatitis
14
Pediatrics
13
HIV & STI
13
Medical Devices & Equipment
11
Virology
10
Parasitology
9
Malaria
9
Policies
8
Disease Prevention & Control
8
Paediatrics
7
Vaccine-preventable Diseases
7
Studies & Reports
7
Buruli Ulcer
6
Bacteriology
6
Capacity Building
6
Reproductive Health
6
Women & Child Health
5
Quality Control & Assurance
5
General Guidelines
4
Gynaecology & Obstetrics
4
Neonatal Care
4
Communicable Diseases
3
Hematology
3
Cancer
3
Cervical Cancer
3
Yersinia pestis (Plague)
3
Countries
3
Diarrhoeal Disease/Cholera
3
NTDs & Others
3
Maternal Health
3
Digital Health
2
Rabies
2
Emergency Health Kits
2
Lymphaticfilariasis
2
Monitoring & Evaluation
2
Cancer Treatment & Resources
2
Infection Control & Prevention (IPC)
2
Snakebites
2
Humanitarian Crisis
2
Immunization
2
Communicable Diseases
2
Health Systems
2
Laboratory Quality Assurance
2
Zika
1
Dental & Eye Care
1
Helminthiasis
1
Under-5 nutrition
1
Child Health
1
Diabetes
1
Hand Hygiene
1
Disaster Preparedness
1
Schistosomiasis
1
Vector Control
1
MPOX - Monkeypox
1
Cardiovascular Diseases
1
Clinical Guidelines
1
Yellow Fever
1
Community Health
1
Disabilities
1
Women & Child Health
1
Primary Health Care
1
Dengue
1
Leishmaniasis
1
Non-communicable Diseases
1
Age & Elderly
1
Radiology and Diagnostic
1
Toolboxes
Diagnostics & Laboratory Guidance
24
Testing Guidelines
21
HIV testing & services
18
Clinical Guidelines
17
Laboratory
16
Drug resistant TB
16
Detection & Diagnosis
15
Country specific documents
14
Adults
10
Children
9
Research & Access
8
Germany
8
Surveillance & Contact tracing
7
Hospital Readiness/Essential Health Services
7
Clinical Aspects & Diagnostics
7
Clinical Aspects, Treatment & Prevention
6
Country specific
6
Global Impact: Socio-economic, health services, TB & HIV
6
Surveillance
5
Prevention & Control
5
Hepatitis
5
Public Health
5
Essential Medicines & Medical Devices
5
SARS-CoV-2 Variants
5
Policies & Strategies
4
Children & Adolescents
4
Treatment Guidelines HIV
4
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
4
Laboratory & Sampling
4
Studies
4
General
4
Infection Control General
4
Scientific & Research Studies
4
Genomic sequencing
4
Traditional & Herbal Medicines
4
MPOX - Monkeypox
4
Access to treatment and laboratory
4
Antiretroviral Treatment ART
4
TB
4
Outbreak Prevention & Control
3
Gynaecology / Obstetrics
3
ART Drug Resistance
3
Childhood TB
3
Laboratory Guidance
3
Agriculture & Veterinary
3
Ebola Prevention & Control
3
Surveillance
3
Treatment & Prevention
3
Vaccines & Immunization
3
Children/Adolescents Mental Disorders
3
Vaccination
3
Prevention & Preparedness
3
Health Personnel
3
Clinical Aspects
3
Public Health
3
PPE Personel Protective Equipment
3
Clinical Guidelines
3
Appeals and Response Plans
3
Oxygen Therapy
3
Quality Assurance
3
Rational use of Medicine
3
Training
3
Stewardship
3
Clinical Guidelines
3
TB/HIV Coinfection
3
Preparedness & Prevention
3
Laboratory & Diagnostics
3
Reports & Studies
3
Eastern Europe and central Asia
3
Plague Prevention & Control
3
Preparedness & Prevention
3
Yellow Fever Prevention & Control
2
Opportunistic Infections
2
Laboratory
2
Cholera Prevention & Control
2
Research
2
Ethiopia
2
International
2
General
2
Supporting tools
2
Context & Facts, Travel Advice
2
Overview & reports
2
Essential Medicines
2
Essential Medicines & Devices Lists
2
Falsified & Substandard
2
Supply Chain & Store Management
2
HIV &TB
2
Emergency health kits
2
Emergency health kits
2
Clinical Aspects & Diagnostics
2
Studies & Reports
2
Leptospirosis
2
Snakebite envenoming
2
Asia and Pacific
2
TB & Prisoners
2
Disease Prevention & Control
2
Dengue Prevention & Control
2
Zika Prevention & Control
2
Paediatrics
2
Capacity Building
2
Alcohol
1
Treatment Guidelines
1
Assessment & Studies
1
Meningitis Prevention & Control
1
IPC
1
Background PTSD in children
1
Europe
1
Clinical Aspects
1
Clinical Guidelines
1
Influenza Prevention & Control
1
HIV surveillance
1
Plague
1
Policies
1
Infection Control
1
HIV testing & disclosure
1
Clinical Guidelines
1
Transgender People
1
Namibia
1
Drug resistance
1
Eastern Europe
1
Surveillance
1
TB
1
Prophylaxis
1
Ebola
1
Human Rights
1
Posttraumatic Stress Disorder in Children
1
Reports
1
Russia
1
Key Resources
1
Context & Facts
1
Treatment Guidelines
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Livestock production
1
Infection Prevention & Hygiene
1
Essential List
1
Hand Hygiene
1
Covid-19 & the One Health Approach
1
For Pregnant Women
1
Training, others
1
Faith-based Organizations
1
Country Specific
1
Paediatrics
1
Physical Distancing
1
Situation Reports COVID-19
1
Non-pharmaceutical interventions (NPIs)
1
TB/HIV
1
Preparedness, Response & Risk Communication
1
Fair Allocation & Ethical Aspects
1
TB/COVID-19
1
Biontech/Pfizer Comirnaty
1
Research & Pipeline
1
Hygiene
1
Hand Hygiene
1
Primary Care
1
Ethics
1
Pharmacy Practice
1
Resuscitation
1
General documents One Health
1
Argentina
1
General Guidelines for Rational Use
1
Pharmacovigilance
1
Capacity Building
1
Guidelines & Manuals
1
Zoonoses
1
Nuclear & Chemical Hazards
1
MPOX - Monkeypox
1
MPOX -Monkeybox Prevention & Control
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Prevention & Control
1
Patient Safety
1
Overview, Studies & Reports
1
Echinocccosis
1
Mycetoma, Chromoblastomycosis & other deep mycosis
1
Yaws & other Endemic Treponematoses
1
Prevention & Strategies
1
Clinical Guidelines
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Children's Rights
1
General
1
Neurological Disorders
1
Substance Use Disorders & Addiction
1
Malawi
1
One Health
1
Prophylactic Treatment
1
Tuberculosis
1
Technical Information
1
Roadmaps, Action Plans & Policies
1
Situation Reports
1
Assessment
1
HIV and coinfection
1
Clinical Guidelines
1
Others
1
Anxiety Disorders
1
HIV service delivery
1
AmR (Region of Americas)
1
South-east Asia Region
1
Laboratory
1
Reports & Studies Children HIV
1
Context & Facts
1
Marburg Virus Situation Reports
1
HIV in Key Populations
1
Eastern Europe & Central Asia
1
Action Plans, Policies & Response
1
Depression
1
Pregnant women
1
Meningitis & Encephalitis
1
Public Health
1
SEAR (South-east Asia Region)
1
Global Burden of Disease
1
The document describes the use of strategic information at various stages of the response in the context of strengthening broader health information systems. Strategic information can be defined as data collected at all service delivery and administrative levels to inform policy and programme decisi...
These guidelines provide a framework for effective action to facilitate access to safe and ethical
testing services for different population groups. The implementation of the a comprehensive
approach, known as HIV Testing Services (HTS) is cardinal as an effective package of services
that diminis...
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals before PrEP is initiated and monitoring while they ar...
The strategy focuses on mobilizing and coordinating partners, experts and resources to help countries enhance surveillance of the Zika virus and disorders that could be linked to it, improve vector control, effectively communicate risks, guidance and protection measures, provide medical care to thos...
This report outlines the Ministry of Health’s National Health Research Agenda in which it identifies research priorities in health. It will be implemented in the same time frame as the Health Sector Strategic Plain 2012-2018. The Ministry of Health being the implementing agency of this document, i...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Prepared as an outcome of ICMR Expert Group on Immunophenotyping of Hematolymphoid Neoplasms | Coordinated by Division of Non Communicable Diseases | This document addresses on various issue related to good quality practices in laboratory work up of flow cytometric immunophenotyping and will be of u...
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMD...
The term "Programmatic Management of Drug Resistant TB" (PMD...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community M...
5 May 2021
This Information Note is intended to assist national TB programmes and health personnel worldwide to maintain essential tuberculosis (TB) services during the COVID-19 pandemic and in the recovery phase. It is important that recent progress made in TB prevention and care is not reversed b...
The document, "Sustainable Management of Radiotherapy Facilities and Equipment," by WHO and IAEA, provides guidelines for managing radiotherapy equipment and facilities to ensure effective and safe cancer treatment. It covers essential aspects like preventive and corrective maintenance, funding, inf...
Au cours de la dernière décennie, les données de séquençage génétique des agents pathogènes ont gagné en importance et contribuent désormais de façon déterminante à la détection et à la maîtrise des flambées de maladies infectieuses, en facilitant la mise au point de ...
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar...
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AMR activities within the Nigerian National Action Plan (NAP)canalready be incorporated within exi...
This manual describes some of the strategic, managerial, financial, technical and scientific aspects to be considered in establishing a national EQA programme for clinical laboratories and other testing services at all health care levels
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities ...
This is the 42nd situation report for the multi-country outbreak of mpox, which provides an update on the epidemiological situation of mpox in Africa (including countries in the WHO African Region and some countries in the WHO Eastern Mediterranean Region), with data as of 3 November 2024.
